Free Trial

Advisor OS LLC Boosts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Advisor OS LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 34.0% during the first quarter, according to its most recent filing with the SEC. The firm owned 4,354 shares of the healthcare conglomerate's stock after purchasing an additional 1,105 shares during the period. Advisor OS LLC's holdings in UnitedHealth Group were worth $2,280,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. Marshall & Sterling Wealth Advisors Inc. acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $26,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at $28,000. Aster Capital Management DIFC Ltd acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at $30,000. Kapitalo Investimentos Ltda acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at $41,000. Finally, Copia Wealth Management acquired a new position in UnitedHealth Group during the fourth quarter worth $42,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Analysts Set New Price Targets

Several research firms have weighed in on UNH. Royal Bank Of Canada lowered their price objective on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Erste Group Bank downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. TD Cowen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a report on Monday, May 19th. Finally, HSBC reiterated a "reduce" rating and issued a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $394.43.

Check Out Our Latest Analysis on UNH

Insiders Place Their Bets

In related news, Director Kristen Gil bought 3,700 shares of the stock in a transaction that occurred on Thursday, May 15th. The shares were acquired at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the purchase, the director directly owned 3,818 shares of the company's stock, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO John F. Rex bought 17,175 shares of the stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the purchase, the chief financial officer directly owned 203,796 shares of the company's stock, valued at $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 109,408 shares of company stock valued at $31,607,768 over the last three months. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH stock traded down $13.99 during trading hours on Thursday, reaching $278.52. The stock had a trading volume of 22,499,738 shares, compared to its average volume of 11,547,906. The stock's fifty day simple moving average is $301.79 and its 200 day simple moving average is $427.21. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The firm has a market capitalization of $252.66 billion, a PE ratio of 11.66, a PEG ratio of 1.45 and a beta of 0.45.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.17%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines